Literature DB >> 32367261

Evaluation of glutamate dehydrogenase (GDH) and toxin A/B rapid tests for Clostridioides (prev. Clostridium) difficile diagnosis in a university hospital in Minas Gerais, Brazil.

Carolina Pantuzza Ramos1, Emily Oliveira Lopes1, Amanda Nádia Diniz1, Francisco Carlos Faria Lobato1, Eduardo Garcia Vilela2,3, Rodrigo Otávio Silveira Silva4.   

Abstract

Clostridioides (Clostridium) difficile is responsible for most cases of nosocomial diarrhea and, despite the high prevalence of the disease worldwide, the best laboratory diagnostic approach to diagnose C. difficile infection (CDI) is a subject of ongoing debate. Although the use of multiple tests is recommended, the cost of these algorithms commonly exceeds the affordability in some countries. Thus, to improve CDI diagnosis in a university hospital in Brazil, this study analyzed two immunochromatographic tests and one enzyme immunoassay (ELISA) to evaluate the detection of glutamate dehydrogenase (GDH) and A/B toxins of C. difficile. Stool samples of 89 adult patients presenting nosocomial diarrhea during hospitalization were included. The toxigenic culture was used as the reference method. GDH detection by both commercial tests showed high sensitivity (100%) and specificity (92.1%). On the other hand, toxin-based methods showed a sensitivity between 19.2 and 57.7%. In conclusion, the results suggest that rapid tests for GDH detection are not only suitable for CDI diagnosis as screening tests but also as a single method.

Entities:  

Keywords:  Nosocomial diarrhea; Pseudomembranous colitis

Year:  2020        PMID: 32367261      PMCID: PMC7455615          DOI: 10.1007/s42770-020-00288-z

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


  23 in total

1.  Antimicrobial prescribing practices in response to different Clostridium difficile diagnostic methodologies.

Authors:  Emily R M Sydnor; Abigail Lenhart; Brandon Trollinger; Edina Avdic; Lisa L Maragakis; Karen C Carroll; Sara E Cosgrove
Journal:  Infect Control Hosp Epidemiol       Date:  2011-09-29       Impact factor: 3.254

Review 2.  Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.

Authors:  Christina M Surawicz; Lawrence J Brandt; David G Binion; Ashwin N Ananthakrishnan; Scott R Curry; Peter H Gilligan; Lynne V McFarland; Mark Mellow; Brian S Zuckerbraun
Journal:  Am J Gastroenterol       Date:  2013-02-26       Impact factor: 10.864

3.  European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection.

Authors:  M J T Crobach; T Planche; C Eckert; F Barbut; E M Terveer; O M Dekkers; M H Wilcox; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2016-07-25       Impact factor: 8.067

Review 4.  How to: Surveillance of Clostridium difficile infections.

Authors:  M Krutova; P Kinross; F Barbut; A Hajdu; M H Wilcox; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2017-12-20       Impact factor: 8.067

5.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

6.  Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.

Authors:  Hsiao-Ju Lin; Yuan-Pin Hung; Hsiu-Chuan Liu; Jen-Chieh Lee; Chih-I Lee; Yi-Hui Wu; Pei-Jane Tsai; Wen-Chien Ko
Journal:  J Microbiol Immunol Infect       Date:  2013-09-21       Impact factor: 4.399

7.  Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection.

Authors:  Timothy D Planche; Kerrie A Davies; Pietro G Coen; John M Finney; Irene M Monahan; Kirsti A Morris; Lily O'Connor; Sarah J Oakley; Cassie F Pope; Mike W Wren; Nandini P Shetty; Derrick W Crook; Mark H Wilcox
Journal:  Lancet Infect Dis       Date:  2013-09-03       Impact factor: 25.071

8.  Comparison of Diagnostic Algorithms for Detecting Toxigenic Clostridium difficile in Routine Practice at a Tertiary Referral Hospital in Korea.

Authors:  Hee-Won Moon; Hyeong Nyeon Kim; Mina Hur; Hee Sook Shim; Heejung Kim; Yeo-Min Yun
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

Review 9.  Clostridium difficile infection: review.

Authors:  Jacek Czepiel; Mirosław Dróżdż; Hanna Pituch; Ed J Kuijper; William Perucki; Aleksandra Mielimonka; Sarah Goldman; Dorota Wultańska; Aleksander Garlicki; Grażyna Biesiada
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-04-03       Impact factor: 3.267

10.  The Role of Glutamate Dehydrogenase (GDH) Testing Assay in the Diagnosis of Clostridium difficile Infections: A High Sensitive Screening Test and an Essential Step in the Proposed Laboratory Diagnosis Workflow for Developing Countries like China.

Authors:  Jing-Wei Cheng; Meng Xiao; Timothy Kudinha; Zhi-Peng Xu; Lin-Ying Sun; Xin Hou; Li Zhang; Xin Fan; Fanrong Kong; Ying-Chun Xu
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

View more
  2 in total

1.  Evaluation of an immunochromatographic test for the detection of glutamate dehydrogenase for the diagnosis of Clostridioides (Clostridium) difficile infection in dogs.

Authors:  Carolina Pantuzza Ramos; Amanda Nádia Diniz; Suzana Martins Leite; Francisco Carlos Faria Lobato; Silvia Trindade Pereira; Mário Cesar Rennó; Eliane de Oliveira Ferreira; Rodrigo Otávio Silveira Silva
Journal:  Braz J Microbiol       Date:  2021-09-25       Impact factor: 2.214

2.  CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy.

Authors:  Mustafa Nissar Bankur; Archie Keeling; Khoodoruth Mohamed Adil Shah; Daniele Avenoso
Journal:  Hematol Rep       Date:  2022-06-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.